top of page
it's where dermatology lives




1/2
New monoclonal antibody shows efficacy in CLE
An early study of litifilimab, a humanized monoclonal antibody, has indicated it may be effective in the treatment of cutaneous lupus...
Allan Ryan
Aug 22, 20222 min read


Signalling molecule moves hair follicle niche fibroblasts to a hyper-activated state
A mesenchymal niche factor signalling molecule called SCUBE3 has been identified by University of California, Irvine (UCI) researchers....
Allan Ryan
Aug 15, 20222 min read
Three micro-RNAs impair venous ulcer healing
Researchers have identified three gene-regulating molecules—micro-RNAs—that seem to impair the healing of venous ulcers. They conclude...
John Evans
Aug 12, 20222 min read


IL-1 may be key in gut-skin inflammation link
Researchers say they have identified how inflammation in the gut can cause the immune system in the skin to lose tolerance for healthy...
John Evans
Jul 15, 20222 min read
Call for entries: Short essay competition for Canadian dermatology residents
Derm.city is pleased to announce a short essay contest on the topic of Inclusivity, Diversity and Equity in Dermatology. The contest is...
Allan Ryan
Jul 11, 20222 min read


Nominations open for 2022 Women in Dermatology showcase
Derm.city is privileged to announce the opening of nominations for the 2022 Women in Dermatology Honour Roll. This website and The...
John Evans
Jul 5, 20221 min read


Protein in sensory nerves acts as sensor for mechanical itch
The protein PIEZO1 in sensory nerves appears to be a key detector of mechanical itch—as opposed to chemically-induced itch caused by...
Allan Ryan
Jun 27, 20222 min read


Study identifies tissue characteristics of stable vitiligo
A new study has utilized multimodal analyses of skin affected by vitiligo in an attempt to provide some answers regarding why white...
Allan Ryan
Jun 20, 20221 min read
Featured Posts


bottom of page
